AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr |
What is the latest Total Non-Current Assets ratio of AUROBINDO PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹21,330 Cr |
Mar2024 | ₹19,653 Cr |
Mar2023 | ₹17,667 Cr |
Mar2022 | ₹15,510 Cr |
Mar2021 | ₹13,578 Cr |
How is Total Non-Current Assets of AUROBINDO PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹21,330 Cr | 8.53 | |
Mar2024 | ₹19,653 Cr | 11.24 | |
Mar2023 | ₹17,667 Cr | 13.90 | |
Mar2022 | ₹15,510 Cr | 14.23 | |
Mar2021 | ₹13,578 Cr | - |
Compare Total Non-Current Assets of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹59,688.8 Cr | -2.2% | -11.3% | -33.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -2.2% |
-11.3% |
-33.7% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses